Literature DB >> 12370175

Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional control.

Valerie Christiaens1, Charlotte L Bevan, Leen Callewaert, Anna Haelens, Guy Verrijdt, Wilfried Rombauts, Frank Claessens.   

Abstract

The androgen receptor interacts with the p160 coactivators via two surfaces, one in the ligand binding domain and one in the amino-terminal domain. The ligand binding domain interacts with the nuclear receptor signature motifs, whereas the amino-terminal domain has a high affinity for a specific glutamine-rich region in the p160s. We here describe the implication of two conserved motifs in the latter interaction. The amino-terminal domain of the androgen receptor is a very strong activation domain constituent of Tau5, which is mainly active in the absence of the ligand binding domain, and Tau1, which is only active in the presence of the ligand binding domain. Both domains are, however, implicated in the recruitment of the p160s. Mutation analysis of the p160s has shown that the relative contribution of the two recruitment mechanisms via the signature motifs or via the glutamine-rich region depend on the nature of the enhancers tested. We propose, therefore, that the androgen receptor-coactivator complex has several alternative conformations, depending partially on the context of the enhancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370175     DOI: 10.1074/jbc.M209322200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  The p160 coactivator PAS-B motif stabilizes nuclear receptor binding and contributes to isoform-specific regulation by thyroid hormone receptors.

Authors:  Martin L Privalsky; Sangho Lee; Johnnie B Hahm; Briana M Young; Rebecca N G Fong; Ivan H Chan
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

2.  Identification and Characterization of the Androgen Receptor From the American Alligator, Alligator mississippiensis.

Authors:  Shinichi Miyagawa; Ryohei Yatsu; Satomi Kohno; Brenna M Doheny; Yukiko Ogino; Hiroshi Ishibashi; Yoshinao Katsu; Yasuhiko Ohta; Louis J Guillette; Taisen Iguchi
Journal:  Endocrinology       Date:  2015-05-14       Impact factor: 4.736

3.  Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells.

Authors:  Manjula Nakka; Irina U Agoulnik; Nancy L Weigel
Journal:  Int J Biochem Cell Biol       Date:  2012-12-25       Impact factor: 5.085

Review 4.  [Inhibitors of the androgen receptor N‑terminal domain : Therapies targeting the Achilles' heel of various androgen receptor molecules in advanced prostate cancer].

Authors:  M C Hupe; A Offermann; F Perabo; C Chandhasin; S Perner; A S Merseburger; M V Cronauer
Journal:  Urologe A       Date:  2018-02       Impact factor: 0.639

5.  Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif.

Authors:  Feng Jin; Frank Claessens; Joseph D Fondell
Journal:  J Biol Chem       Date:  2011-11-18       Impact factor: 5.157

Review 6.  Androgen receptor gene rearrangements: new perspectives on prostate cancer progression.

Authors:  Lucas J Brand; Scott M Dehm
Journal:  Curr Drug Targets       Date:  2013-04       Impact factor: 3.465

7.  Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.

Authors:  Katja Jehle; Laura Cato; Antje Neeb; Claudia Muhle-Goll; Nicole Jung; Emmanuel W Smith; Victor Buzon; Laia R Carbó; Eva Estébanez-Perpiñá; Katja Schmitz; Ljiljana Fruk; Burkhard Luy; Yu Chen; Marc B Cox; Stefan Bräse; Myles Brown; Andrew C B Cato
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

Review 8.  Constitutive activity of the androgen receptor.

Authors:  Siu Chiu Chan; Scott M Dehm
Journal:  Adv Pharmacol       Date:  2014

9.  Functional conservation of the glutamine-rich domains of yeast Gal11 and human SRC-1 in the transactivation of glucocorticoid receptor Tau 1 in Saccharomyces cerevisiae.

Authors:  Dae-Hwan Kim; Gwang Sik Kim; Chul Ho Yun; Young Chul Lee
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

Review 10.  Polyglutamine androgen receptor-mediated neuromuscular disease.

Authors:  Elisa Giorgetti; Andrew P Lieberman
Journal:  Cell Mol Life Sci       Date:  2016-05-17       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.